Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Depreciation & Amortization (CF) (2020 - 2025)

Vivos Therapeutics has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $442000.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 206.94% to $442000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 125.3% year-over-year, with the annual reading at $1.3 million for FY2025, 125.3% up from the prior year.
  • Depreciation & Amortization (CF) was $442000.0 for Q4 2025 at Vivos Therapeutics, up from $384000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $442000.0 in Q4 2025 and troughed at $41000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $172000.0 (2022), against an average of $195613.6.
  • Year-over-year, Depreciation & Amortization (CF) tumbled 76.84% in 2022 and then surged 326.83% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $168000.0 in 2021, then increased by 0.6% to $169000.0 in 2022, then dropped by 11.83% to $149000.0 in 2023, then dropped by 3.36% to $144000.0 in 2024, then surged by 206.94% to $442000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Depreciation & Amortization (CF) are $442000.0 (Q4 2025), $384000.0 (Q3 2025), and $306000.0 (Q2 2025).